alexa Sahdeo Prasad | The University of Texas
ISSN: 2379-1764

Advanced Techniques in Biology & Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Sahdeo Prasad

Sahdeo Prasad Sahdeo Prasad
The University of Texas
MD Anderson Cancer Center

"Dr. Sahdeo Prasad obtained his Ph.D. (Biotechnology), CSJM University, Kanpur, India and Indian Institute of Toxicology Research (CSIR), Lucknow, India in 2010. During doctoral research program, he extensively worked on signal transduction pathways in both in vivo and in vitro tumor models. Before joining his PhD program, Dr. Prasad received National Eligibility Test (CSIR - UGC-NET), Graduate Aptitude Test in Engineering (GATE) and Indian Council of Medical Research Junior Research Fellowship award (ICMR-JRF) by Govt. of India in 2003. After PhD, he joined as Post - Doctoral Fellow in Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, USA. His expertise is in the area of molecular biology with particular reference to molecular mechanisms of signal transduction in tumor cells. Dr. Prasad has discovered a number of phytochemicals with chemo-preventive effects against a variety of cancers and their mechanism of action. The current research focuses of Dr. Prasad are on investigating the effects of chemo-preventive and chemotherapeutic agents among natural products that could suppress the activation of pro-inflammatory transcription factors NF-kB and STAT3. Besides these, Dr. Prasad’s work is also focused on the effect of natural compounds on death receptor pathways, bone loss and chemosensitization of tumor cells. He has over 80 National and International publications, abstracts Indexed in 10 International conferences. He is also an editorial board member of various reputed journals."

Research Interest

Study of transcription factors NF-kappaB and STAT3 signaling pathway, death receptor pathway, extrinsic and intrinsic pathway of apoptosis, anticancer properties of natural compounds in both in vitro and nude mouse models, study of cell cycle by flow cytometry, study of oxidative stress in animal models, antioxidants, study of genotoxicity by chromosomal aberration and micronuclei assay, study of gene expression by using western blotting and RT - PCR, DNA binding assay by EMSA, reporter gene expression, Immunohistochemical analysis, studies on both in vivo and in vitro experimental models. 



Molecular Targets of Curcumin: A Potential Magic Bullet for Health
Amit Kumar Tyagi and Sahdeo Prasad
Editorial: Mol Biol 2015, 4: 123
DOI: 10.4172/2168-9547.1000e123
Drug Discovery Inspired by Mother Nature for Cancer Therapy
Amit Kumar Tyagi and Sahdeo Prasad
Editorial: Biochem Physiol 4: e128
DOI: 10.4172/2168-9652.1000e128
Volatile Phytochemicals: Potential Role in Food Safety and Preservation
Amit K. Tyagi and Sahdeo Prasad
Editorial: Air Water Borne Diseases
DOI: 10.4172/2167-7719.1000e133
Traditional Medicine: The Goldmine for Modern Drugs
Sahdeo Prasad, Amit Kumar Tyagi
Editorial: Adv Tech Biol Med 2015, 3: e108
DOI: 10.4172/2379-1764.1000e108
Chronic Diseases Caused by Chronic Inflammation Require Chronic Treatment: Anti-inflammatory Role of Dietary Spices
Sahdeo Prasad and Bharat B. Aggarwal
Review Article: J Clin Cell Immunol 2014, 5: 238
DOI: 10.4172/2155-9899.1000238
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version